Literature DB >> 23560296

Association between vitiligo extent and distribution and quality-of-life impairment.

Jonathan I Silverberg1, Nanette B Silverberg.   

Abstract

OBJECTIVE: To determine whether the extent, distribution, and duration of vitiligo are associated with impairment of specific aspects of quality of life.
DESIGN: A prospective questionnaire-based study of 1541 adults with vitiligo.
SETTING: Online questionnaire. MAIN OUTCOME MEASURES: Affected body surface area (BSA), distribution and duration of vitiligo, associated symptoms, and quality of life using the Dermatology Life Quality Index (DLQI).
RESULTS: Vitiligo had a negative effect on numerous aspects and the total score of the DLQI (mean [SD], 5.9 [5.5]). The DLQI scores in vitiligo were associated with an affected BSA of more than 25% (ordinal logistic regression; adjusted odds ratio, 2.17 [95% CI, 1.71-2.75; P<.001]) and number of body parts affected with vitiligo (P≤.009) but not laterality (P=.06) or duration of disease (P≥.54). Itching and/or burning skin occurred in a sizable percentage of vitiligo patients (35.1%) and were predicted by an affected BSA of more than 25% (adjusted odds ratio, 1.59 [95% CI, 1.26-2.01; P<.001]). Sexual dysfunction occurred in 18% of patients and was predicted by an affected BSA of more than 25% (adjusted odds ratio, 1.94 [95% CI, 1.44-2.61; P<.001]) and vitiligo lesions in the genital area (1.82 [1.30-2.53; P<.001]).
CONCLUSIONS: Vitiligo extent is associated with increased quality-of-life impairment, including itching and sexual dysfunction. Moreover, different distributions of vitiligo lesions are associated with impairment of different aspects of quality of life. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01401374

Entities:  

Mesh:

Year:  2013        PMID: 23560296     DOI: 10.1001/jamadermatol.2013.927

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  19 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

Review 3.  [Dermatological diseases and sexuality. How to proceed?].

Authors:  F-M Köhn; H-C Schuppe; K M Beier
Journal:  Hautarzt       Date:  2015-12       Impact factor: 0.751

Review 4.  Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.

Authors:  Mark Nestor; Vivian Bucay; Valerie Callender; Joel L Cohen; Neil Sadick; Heidi Waldorf
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

Review 5.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

6.  Vitiligo: Patient stories, self-esteem, and the psychological burden of disease.

Authors:  P E Grimes; M M Miller
Journal:  Int J Womens Dermatol       Date:  2018-01-08

Review 7.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

Review 8.  Sexual disorders in patients with vitiligo.

Authors:  Amira Maamri; Talel Badri
Journal:  Tunis Med       Date:  2021 Mai

9.  Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients.

Authors:  Claire Regazzetti; Florence Joly; Carine Marty; Michel Rivier; Bruno Mehul; Pascale Reiniche; Carine Mounier; Yves Rival; David Piwnica; Marine Cavalié; Bérengère Chignon-Sicard; Robert Ballotti; Johannes Voegel; Thierry Passeron
Journal:  J Invest Dermatol       Date:  2015-08-31       Impact factor: 8.551

10.  Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese.

Authors:  Juliana Catucci Boza; Roopal V Kundu; Amanda Fabbrin; Roberta Horn; Natalia Giongo; Tania Ferreira Cestari
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.